Evidence map›Paper›PMID 42598860›Full record

ArticleNucleic acids research2026

CRISPR RNA architecture steers Cas9 catalysis and fidelity via a guide repeat clasp motif.

Ramadevi Chilamkurthy, Sruthi Sudhakar, Adrian A Pater, Michael S Bosmeny, Francis Stabile, Adam Katolik, S Harikrishna, Fatima El Azzouzi, Rolf Turk, Masad J Damha and 4 more

Abstract read
In one paragraph

Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Ramadevi ChilamkurthyDepartment of Biochemistry, Wake Forest University School of Medicine, Winston-Salem, NC, United States.
Sruthi SudhakarDepartment of Chemistry, Indian Institute of Technology Bombay, Powai, Mumbai, India.
Adrian A PaterDepartment of Biochemistry, Wake Forest University School of Medicine, Winston-Salem, NC, United States.
Michael S BosmenyDepartment of Biochemistry, Wake Forest University School of Medicine, Winston-Salem, NC, United States.
Francis StabileDepartment of Physics, McGill University, Montreal, Quebec, Canada.
Adam KatolikDepartment of Chemistry, McGill University, Montreal, Quebec, Canada.
S HarikrishnaDepartment of Chemistry, Indian Institute of Technology Bombay, Powai, Mumbai, India.
Fatima El AzzouziDepartment of Biochemistry, Wake Forest University School of Medicine, Winston-Salem, NC, United States.
Rolf TurkIntegrated DNA Technologies, Coralville, IA, United States.
Masad J DamhaDepartment of Chemistry, McGill University, Montreal, Quebec, Canada.ORCID 0000-0002-4458-1623
Sabrina LeslieDepartment of Physics, McGill University, Montreal, Quebec, Canada.
Sergey KorolevDepartment of Biochemistry and Molecular Biology, School of Medicine, Saint Louis University, St. Louis, MO, United States.ORCID 0000-0001-9313-7126
P I PradeepkumarDepartment of Chemistry, Indian Institute of Technology Bombay, Powai, Mumbai, India.
Keith T GagnonDepartment of Biochemistry, Wake Forest University School of Medicine, Winston-Salem, NC, United States.ORCID 0000-0002-5868-675X

Funding

Nucleic Acid-Based Anti-CRISPR Inhibitors of Cas9R01GM135646 · NIGMS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI GAGNON, KEITH THOMAS · 2020 to 2023
$1.1M
Mechanism of homologous recombination driven by the intrinsically disordered domain of tumor suppressor PALB2R01GM154323 · NIGMS · SAINT LOUIS UNIVERSITY · PI SERGEY KOROLEV · 2024 to 2026
$1.1M
NIGMS NIH HHS R01 GM135646NIGMS NIH HHS R01 GM154323NIH HHS 1R01GM135646NIH HHS R01GM154323
6 · The paper itself

Abstract

A widely adopted modification of CRISPR-Cas9 is fusion of the naturally occurring two-component dual guide RNA (dgRNA) to create an artificial single guide RNA (sgRNA). Here we find that these guide architectures induce differential catalysis, gene editing, and specificity. Spacer sequence and RNA structural features could not predict guide architecture editing preference across 255 endogenous targets. We used cryo-EM and molecular dynamics to identify a new Cas9 structural motif, the guide repeat clasp (GRC), that checks guide RNA repeat structure and coordinates with R-loop sensing checkpoint mechanisms to help license cleavage. Limited mutagenesis of GRC residues significantly altered Cas9 editing and specificity, supporting a key role in catalysis. To further understand the role of the GRC and guide RNA repeat dynamics, we created guide repeat-truncated sgRNAs, or grtRNAs, which conferred some dgRNA properties onto sgRNA, including generally lower off-target editing for targets with PAM-proximal mismatches. dgRNAs and grtRNAs could be combined with a new high-fidelity Cas9 variant called ZiFY, rationally designed to reduce editing of targets with PAM-distal mismatches, to generate broader mismatched target discrimination. These results uncover a previously unknown mechanism that steers Cas9 catalysis and demonstrate the potential to improve Cas9 fidelity by modulating guide repeat interactions.

Indexed as

CRISPR-Cas SystemsRNA, Guide, CRISPR-Cas SystemsBase SequenceBiocatalysisRNA, Guide, CRISPR-Cas Systems

Identifiers

PMID42598860
PMCPMC13473882

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.